2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of thePsychedelic Drugs Market?

The escalating number of mental illness cases is predicted to stimulate the expansion of the psychedelic drugs market. These health-related conditions, referred to as mental illnesses, are marked by alterations in emotional, thought, or behavioral patterns and encompass conditions like distress and post-traumatic stress disorder. Psychedelic drugs are used as a treatment for depression and post-traumatic stress disorder, with their consistent use helping to reduce mental illnesses. This is exemplified by data from the National Centre for Social Research in UK, which revealed that the ratio of 17- to 19-year-olds suspected of having a mental disorder shot up from 17.4% in 2021 to 25.7% in 2022. Consequently, the rise in mental illness cases is fuelling the psychedelic drugs market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

#What is the Growth Potential of the Psychedelic Drugs Market, and How Will It Perform by 2034?

The market size of psychedelic drugs has seen a swift expansion in the past few years. It is set to balloon from $5.56 billion in 2024 to $6.39 billion in 2025, at a compound annual growth rate (CAGR) of 14.9%. The dramatic increase in the historic period is credited to changing governmental regulations, rise in awareness about mental health, and evolving public opinion.

Expectations are high for the psychedelic drugs market to experience a quick expansion in the upcoming years. The market size is projected to reach $11.93 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. The growth can be credited to breakthroughs in drug research, broadening therapeutic uses, rising acceptance among medical professionals, changes in public policy, and reactions to the mental health crisis. The forecast period sees an emphasis on promoting education and public awareness, as well as key trends such as legal and regulatory progress, diversification in psychedelic substances, and a focus on treatment methods that prioritize the patient.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

Which Upcoming Market Trends and Innovations Are Set to Influence thePsychedelic Drugs Market’s Path Forward?

Key players in the psychedelic drugs market are concentrating on groundbreaking products like ketamine in a bid to bolster therapeutic results for mental health diseases, widen patient access to therapies, and delve into fresh uses for psychedelic substances in fields such as depression, anxiety, PTSD, and substance misuse disorders. Ketamine, famed for its dissociative characteristics, is a prescription medication traditionally used as an analgesic and anesthetic. It’s presently under investigation for its fast-acting antidepressant effects in treating serious depression and PTSD. For example, traditional US company Husch Blackwell unveiled the Psychedelics and Emerging Therapies Practice Group in March 2022. This group has a mandate to aid pioneers in studying, crafting, and unleashing innovative treatments built on psychedelics. It consists of a cross-disciplinary group of legal experts experienced in dealing with the intricate legalities associated with these substances, often designated as Schedule I controlled substances under U.S. federal legislation. This categorization introduces considerable regulatory obstacles that can obstruct research and development pursuits.

Who Are the Dominant Market Players Pushing the Boundaries of thePsychedelic Drugs Market?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

What Are the Core Segments of the Psychedelic Drugs Market, and How Do They Contribute to Growth?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

What Regions Are Dominating the Psychedelic Drugs Market Growth?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2025, By The Business Research Company:

Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soy-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

Protein Inhibitors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: